Top questions a securities lawyer will ask an STO issuer – Bankless Times banklesstimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from banklesstimes.com Daily Mail and Mail on Sunday newspapers.
Share:
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the Company ) is pleased to announce the closing of its previously announced reverse takeover transaction (the Transaction ) with Avisa Pharma Inc. ( Avisa ). In accordance with the merger agreement and plan of reorganization dated February 1, 2021 (the Merger Agreement ), which superseded and replaced the previously announced Letter of Intent dated January 12, 2021, the Transaction was effected by way of a triangular merger between the Company, Avisa, and a wholly owned, Delaware subsidiary of the Company ( Subco ) pursuant to the laws of the State of Delaware. The combined public company resulting from the Transaction (the Resulting Issuer ) will carry on the business of Avisa.
TSX Venture Exchange revamps capital pool program theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.